Effects of azathioprine and mizoribine on aggregation of normal and uremic platelets.
Malyszko
J S
JS
Department of Nephrology, Bialystok Medical School, Poland.
Malyszko
J
J
Pawlak
K
K
Mysliwiec
M
M
Takada
Y
Y
Takada
A
A
D000244:Adenosine Diphosphate / Q000494:pharmacology; D016718:Arachidonic Acid / Q000494:pharmacology; D001379:Azathioprine / Q000494:pharmacology*; D003094:Collagen / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy; D010974:Platelet Aggregation / Q000187:drug effects*; D012016:Reference Values; D006435:Renal Dialysis; D012263:Ribonucleosides / Q000494:pharmacology*; D012310:Ristocetin / Q000494:pharmacology; D012701:Serotonin / Q000097:blood; D014511:Uremia / Q000097:blood* / Q000628:therapy
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; D012310:Ristocetin; D016718:Arachidonic Acid; D012701:Serotonin; C010052:mizoribine; D000244:Adenosine Diphosphate; D003094:Collagen; D001379:Azathioprine